Mu Ju-Wei, Gao Shu-Geng, Xue Qi, Zhao Jun, Li Ning, Yang Kun, Su Kai, Yuan Zhu-Yang, He Jie
Department of Thoracic Surgery, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Chin Med J (Engl). 2015 Oct 20;128(20):2731-5. doi: 10.4103/0366-6999.167298.
Both uniportal and triportal thoracoscopic lobectomy and sublobectomy are feasible for early-stage non-small cell lung cancer (NSCLC). The aim of this study was to compare the perioperative outcomes of uniportal and triportal thoracoscopic lobectomy and sublobectomy for early-stage NSCLC.
A total of 405 patients with lung lesions underwent thoracoscopic lobectomy or sublobectomy through a uniportal or triportal procedure in approximately 7-month period (From November 2014 to May 2015). A propensity-matched analysis, incorporating preoperative variables, was used to compare the short-term outcomes of patients who received uniportal or triportal thoracoscopic lobectomy and sublobectomy.
Fifty-eight patients underwent uniportal and 347 patients underwent triportal pulmonary resection. The conversion rate for uniportal and triportal procedure was 3.4% (2/58) and 2.3% (8/347), respectively. The complication rate for uniportal and triportal procedure was 10.3% and 9.5%, respectively. There was no perioperative death in either group. Most patients had early-stage NSCLC in both groups (uniportal: 45/47, 96%; triportal: 313/343, 91%). Propensity score-matching analysis demonstrated no significant differences in operation time, intraoperative blood loss, numbers of dissected lymph nodes, number of stations of lymph node dissected, duration of chest tube, and complication rate between uniportal and triportal group for early-stage NSCLC. However, the duration of postoperative hospitalization was longer in the uniportal group (6.83 ± 4.17 vs. 5.42 ± 1.86 d, P = 0.036) compared with the triportal group.
Uniportal thoracoscopic lobectomy and sublobectomy is safe and feasible, with comparable short-term outcomes with triportal thoracoscopic pulmonary resection. Uniportal lobectomy and sublobectomy lead to similar cure rate as triportal lobectomy and sublobectomy for early NSCLC.
单孔和三孔胸腔镜肺叶切除术及肺段切除术对于早期非小细胞肺癌(NSCLC)均可行。本研究旨在比较单孔和三孔胸腔镜肺叶切除术及肺段切除术治疗早期NSCLC的围手术期结果。
在大约7个月的时间里(2014年11月至2015年5月),共有405例肺部病变患者接受了单孔或三孔胸腔镜肺叶切除术或肺段切除术。采用倾向评分匹配分析,纳入术前变量,比较接受单孔或三孔胸腔镜肺叶切除术及肺段切除术患者的短期结果。
58例患者接受单孔手术,347例患者接受三孔肺切除术。单孔和三孔手术的中转率分别为3.4%(2/58)和2.3%(8/347)。单孔和三孔手术的并发症发生率分别为10.3%和9.5%。两组均无围手术期死亡。两组大多数患者为早期NSCLC(单孔组:45/47,96%;三孔组:313/343,91%)。倾向评分匹配分析显示,早期NSCLC的单孔组和三孔组在手术时间、术中出血量、清扫淋巴结数量、清扫淋巴结站数、胸管留置时间和并发症发生率方面无显著差异。然而,与三孔组相比,单孔组术后住院时间更长(6.83±4.17天 vs. 5.42±1.86天,P = 0.036)。
单孔胸腔镜肺叶切除术及肺段切除术安全可行,与三孔胸腔镜肺切除术的短期结果相当。对于早期NSCLC,单孔肺叶切除术及肺段切除术与三孔肺叶切除术及肺段切除术的治愈率相似。